PwC launched DoubleJump Health, a consumer health accelerator that is looking to “speed the pace of innovation in person-centered health.” There are two solutions which, according to PwC, are first to launch: DoubleJump Interchange, aimed at breaking down barriers for ecosystem collaboration, data integration and analysis; and Bodylogical from DoubleJump Health, which will help predict chronic health outcomes at an individual and population level.
“We believe that in order to thrive in the New Health Economy, businesses need more than a competitive edge. They must accelerate — even leapfrog — innovation. And that’s where DoubleJump Health comes in,” Kelly Barnes, partner, PwC Health Industries practice leader, said in a statement. “PwC’s investment in this area is game-changing for our clients and the healthcare industry in order to meet the complex challenges of the future.”
DoubleJump Interchange enables traditional and nontraditional healthcare stakeholders to connect into a cloud-based interchange to share data, information, research and best practices across an enterprise or between organizations. The platform aims to bring together the right partners for a purposeful exchange of information to improve the health of consumers. For example, DoubleJump Interchange can help connect the dots between a patient’s wearable device data collected at home, to their vital signs taken at a retail clinic, to their historical health data stored with their primary care doctor.
DoubleJump Interchange enables healthcare stakeholders to share data, information, research and best practices.The second offering, Bodylogical from DoubleJump Health, is a scientifically developed digital model of the human body that enables true-life simulations to predict the likely progression of chronic diseases in the future based on today’s actions and interventions. The solution enables pharmaceutical companies, providers, payers, employers, researchers and consumers to better understand how interventions impact individual patients or patient populations in order to become healthier faster and less expensively. This, according to PwC, creates a “virtual consumer” that can be manipulated to see how one change in the body impacts other systems and overall health.
“With Bodylogical, we can go beyond big data and look forward to show the impact of health choices before they are made,” Paul D’Alessandro, principal at PwC Health Industries, said in a statement.